The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease. Quantitative CT analysis

Academic Radiology

Volumn 18, Issue 1, 2011, Pages 40-46

  Matsuoka, Shin ^a,c   Yamashiro, Tsuneo ^a   Diaz, Alejandro ^a,b   San José Estépar, Raúl ^a   Ross, James C ^a   Silverman, Edwin K ^a   Kobayashi, Yasuyuki ^c   Dransfield, Mark T ^d   Bartholmai, Brian J ^e   Hatabu, Hiroto ^a   Washko, George R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Mayo Clinic   (United States)

Author keywords

Atherosclerosis; Chronic obstructive; Computed tomography; Pulmonary artery; Systemic inflammation

Indexed keywords

ADULT; AGED; AORTA ATHEROSCLEROSIS; ARTERY CALCIFICATION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EMPHYSEMA; FEMALE; HEALTH INSURANCE; HUMAN; IMAGE ANALYSIS; INFORMED CONSENT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY VASCULAR DISEASE; RETROSPECTIVE STUDY; SPIROMETRY;

AGED; AGED, 80 AND OVER; AORTIC DISEASES; ARTERIOSCLEROSIS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649906799     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2010.08.013     Document Type: Article

References (50)

1. Gan W.Q., Man S.F., Senthilselvan A., et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580.
2. Donaldson G.C., Seemungal T.A., Patel I.S., et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005, 128:1995-2004.
3. Pinto-Plata V.M., Müllerova H., Toso J.F., et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006, 61:23-28.
4. Palange P., Testa U., Huertas A., et al. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J 2006, 27:529-541.
5. Sin D.D., Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003, 107:1514-1519.
6. Man S.F., Connett J.E., Anthonisen N.R., et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006, 61:849-853.
7. Anthonisen N.R., Connett J.E., Enright P.L., et al. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002, 166:333-339. Lung Health Study Research Group.
8. Calverley P.M., Anderson J.A., Celli B., et al. TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775-789.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
10. Faxon D.P., Fuster V., Libby P., et al. Atherosclerotic vascular disease conference: writing group iii: pathophysiology. Circulation 2004, 109:2617-2625.
11. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
12. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003, 23:168-175.
13. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-1241.
14. Neunteufl T., Katzenschlager R., Hassan A., et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997, 129:111-118.
15. Barr R.G., Mesia-Vela S., Austin J.H., et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med 2007, 176:1200-1207.
16. McAllister D.A., Maclay J.D., Mills N.L., et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 176:1208-1214.
17. Mills N.L., Miller J.J., Anand A., et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 2008, 63:306-311.
18. Eickhoff P., Valipour A., Kiss D., et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 178:1211-1218.
19. Iwamoto H., Yokoyama A., Kitahara Y., et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009, 179:35-40.
20. Sabit R., Bolton C.E., Edwards P.H., et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 175:1259-1265.
21. Bostrom K., Watson K.E., Horn S., et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993, 91:1800-1809.
22. Shanahan C.M., Cary N.R., Metcalfe J.C., et al. High expression of genes for calcification-regulating proteins in human atherosclerotic plaque. J Clin Invest 1994, 93:2393-2402.
23. Witteman J.C., Kannel W.B., Wolf P.A., et al. Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol 1990, 66:1060-1064.
24. Takasu J., Katz R., Nasir K., et al. Relationships of thoracic aortic wall calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2008, 155:765-771.
25. Eisen A., Tenenbaum A., Koren-Morag N., et al. Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation 2008, 118:1328-1334.
26. Takasu J., Mao S., Budoff M.J. Aortic atherosclerosis detected with electron-beam CT as a predictor of obstructive coronary artery disease. Acad Radiol 2003, 10:631-637.
27. Takasu J., Katz R., Shavelle D.M., et al. Inflammation and descending thoracic aortic calcification as detected by computed tomography: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2008, 199:201-206.
28. Kasahara Y., Tuder R.M., Taraseviciene-Stewart L., et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000, 106:1311-1319.
29. Santos S., Peinado V.I., Ramirez J., et al. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167:1250-1256.
30. Peinado V.I., Barberá J.A., Abate P., et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:1605-1611.
31. Matsuoka S., Washko G.R., Dransfield M.T., et al. Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad Radiol 2010, 17:93-99.
32. Matsuoka S., Washko G.R., Yamashiro T., et al. Pulmonary hypertension and CT measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med 2010, 181:218-225. National Emphysema Treatment Trial Research Group.
33. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
34. Coche E., Pawlak S., Dechambre S., et al. Peripheral pulmonary arteries: identification at multi-slice spiral CT with 3D reconstruction. Eur Radiol 2003, 13:815-822.
35. Shemesh J., Apter S., Rozenman J., et al. Calcification of coronary arteries: detection and quantification with double-helix CT. Radiology 1995, 197:779-783.
36. Agaston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
37. Eisen A., Tenenbaum A., Koren-Morag N., et al. Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation 2008, 118:1328-1334.
38. Wu M.H., Chern M.S., Chen L.C., et al. Electron beam computed tomography evidence of aortic calcification as an independent determinant of coronary artery calcification. J Chin Med Assoc 2006, 69:409-414.
39. Gevenois P.A., de Maertelaer V., De Vuyst P., et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995, 152:653-657.
40. Chaouat A., Savale L., Chouaid C., et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest 2009, 136:678-687.
41. Maclay J.D., McAllister D.A., Mills N.L., et al. Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 180:513-520.
42. Schünemann H.J., Dorn J., Grant B.J., et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000, 118:656-664.
43. Bang K.M., Gergen P.J., Kramer R., et al. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 1993, 103:536-540.
44. Friedman G.D., Klatsky A.L., Siegelaub A.B. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976, 294:1071-1075.
45. Hale K.A., Niewoehner D.E., Cosio M.G. Morphologic changes in the muscular pulmonary arteries: relationship to cigarette smoking, airway disease, and emphysema. Am Rev Respir Dis 1980, 122:273-278.
46. Wright J.L., Lawson L., Pare P.D., et al. The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease. The effect of oxygen and exercise. Am Rev Respir Dis 1983, 128:702-707.
47. Santos S., Peinado V.I., Ramirez J., et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J 2002, 19:632-638.
48. Kasahara Y., Tuder R.M., Cool C.D., et al. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 2001, 163:737-744.
49. Kanazawa H., Asai K., Hirata K., Yoshikawa J. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 2003, 114:354-358.
50. Schroeder E.B., Welch V.L., Evans G.W., et al. Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis 2005, 180:367-373.